HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elena Andreucci Selected Research

NVP-AST487

12/2016Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elena Andreucci Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 07/2009
14Melanoma (Melanoma, Malignant)
01/2022 - 03/2015
4Acidosis
01/2022 - 12/2017
3Neoplasm Metastasis (Metastasis)
07/2021 - 12/2016
2Breast Neoplasms (Breast Cancer)
12/2019 - 12/2016
2Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
11/2009 - 09/2009
2Sensorineural Hearing Loss
11/2009 - 09/2009
1Idiopathic Pulmonary Fibrosis
05/2022
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
10/2021
1Stomach Neoplasms (Stomach Cancer)
07/2021
1Noonan Syndrome (Female Pseudo-Turner Syndrome)
01/2021
1Disease Progression
12/2020
1Colonic Neoplasms (Colon Cancer)
12/2019
1Colorectal Neoplasms (Colorectal Cancer)
12/2019
1Metatropic dwarfism
07/2017
1Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
07/2017
1Pathologic Processes
01/2017
1Residual Neoplasm
01/2017
1Microphthalmos
05/2016
1Macular Degeneration (Age-Related Maculopathy)
05/2016
1Optic Nerve Hypoplasia
05/2016
1Oculocutaneous Albinism (Albinism, Yellow Mutant)
09/2015

Drug/Important Bio-Agent (IBA)

5Carbonic Anhydrase IXIBA
12/2020 - 12/2017
4Urokinase Plasminogen Activator ReceptorsIBA
01/2022 - 01/2019
4VemurafenibIBA
01/2022 - 11/2017
4SLC-0111IBA
12/2020 - 12/2017
3Biological ProductsIBA
05/2022 - 12/2018
3IntegrinsIBA
05/2022 - 03/2015
3Pharmaceutical PreparationsIBA
01/2022 - 12/2017
2Oxygen (Dioxygen)IBA
01/2022 - 11/2018
2oleuropeinIBA
10/2021 - 12/2018
2Fluorouracil (Carac)FDA LinkGeneric
07/2021 - 12/2019
2Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2019
2Conditioned Culture MediaIBA
03/2021 - 12/2020
2Peptides (Polypeptides)IBA
03/2021 - 01/2019
2AcidsIBA
10/2020 - 09/2009
2olive leaf extractIBA
01/2020 - 12/2018
2Dacarbazine (DIC)FDA LinkGeneric
12/2019 - 12/2018
2Sunitinib (Sutent)FDA Link
01/2019 - 12/2016
2EverolimusFDA Link
12/2018 - 11/2017
2DNA (Deoxyribonucleic Acid)IBA
04/2011 - 07/2009
2dirhodium tetraacetate (DRTA)IBA
11/2009 - 09/2009
1Tyrosine Kinase InhibitorsIBA
05/2022
1nintedanibIBA
05/2022
1Antifibrotic AgentsIBA
05/2022
1Cyclic PeptidesIBA
05/2022
1ParaffinIBA
01/2022
1Aldehyde DehydrogenaseIBA
07/2021
1Paclitaxel (Taxol)FDA LinkGeneric
07/2021
1Cisplatin (Platino)FDA LinkGeneric
07/2021
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
07/2021
1Adenosine Triphosphate (ATP)IBA
07/2021
1Gefitinib (Iressa)FDA Link
03/2021
1cadherin 5IBA
03/2021
13' Untranslated Regions (3' UTR)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
01/2021
1Histone Deacetylases (Histone Deacetylase)IBA
12/2020
1VorinostatFDA Link
12/2020
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
12/2020
1Histone Deacetylase InhibitorsIBA
12/2020
1Lactic Acid (Lactate)FDA LinkGeneric
10/2020
1Plasminogen Activators (Plasminogen Activator)IBA
01/2020
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2020
1Drug CombinationsIBA
12/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
12/2019
1Complement System Proteins (Complement)IBA
12/2019
1Temozolomide (Temodar)FDA LinkGeneric
12/2019
1Cytostatic AgentsIBA
12/2019
1HLA-B Antigens (HLA-B)IBA
08/2019
1Monoclonal AntibodiesIBA
08/2019
1EnzymesIBA
08/2019
1Histocompatibility Antigens Class IIBA
08/2019
1Sepharose (Agarose)IBA
01/2019
1PolyphenolsIBA
12/2018
1PlasticsIBA
11/2018
1CationsIBA
07/2017
1Transient Receptor Potential ChannelsIBA
07/2017
1CalciumIBA
07/2017
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2017
1Protein Isoforms (Isoforms)IBA
01/2017
1Estrogen ReceptorsIBA
12/2016
1Aromatase InhibitorsIBA
12/2016
1Phosphotransferases (Kinase)IBA
12/2016
1Proto-Oncogene Proteins c-retIBA
12/2016
1NVP-AST487IBA
12/2016
1Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
12/2016
1NVP-BBT594IBA
12/2016
1cabozantinibIBA
12/2016
1Aromatase (CYP19)IBA
12/2016
1Estrogens (Estrogen)FDA Link
12/2016
1Letrozole (Femara)FDA LinkGeneric
12/2016
1Retinaldehyde (Retinal)IBA
05/2016
1Growth Hormone (Somatotropin)IBA
05/2016

Therapy/Procedure

10Therapeutics
01/2022 - 12/2016
5Drug Therapy (Chemotherapy)
07/2021 - 12/2018
1Radiotherapy
12/2019
1Aftercare (After-Treatment)
01/2017